{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Thiazole", "anticancer", "naphthalene", "tubulin", "tubulin polymerisation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34309466", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2021.1958213"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "36", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.", "Pagination": {"StartPage": "1694", "EndPage": "1702", "MedlinePgn": "1694-1702"}, "Abstract": {"AbstractText": ["A novel series of thiazole-naphthalene derivatives as tubulin polymerisation inhibitors were designed, synthesised, and evaluated for the anti-proliferative activities. The majority of the tested compounds exhibited moderate to potent antiproliferative activity on the MCF-7 and A549 cancer cell lines. Among them, compound <b>5b</b> was found to be the most active compound with IC<sub>50</sub> values of 0.48\u2009\u00b1\u20090.03 and 0.97\u2009\u00b1\u20090.13\u2009\u03bcM. Moreover, mechanistic studies revealed that <b>5b</b> significantly inhibited tubulin polymerisation with an IC<sub>50</sub> value of 3.3\u2009\u00b5M, as compared to the standard drug colchicine (IC<sub>50</sub> = 9.1\u2009\u03bcM). Further cellular mechanism studies elucidated that <b>5b</b> arrested the cell cycle at G2/M phase and induced apoptosis in MCF-7 cancer cells. Molecular modelling study indicated that <b>5b</b> binds well to the colchicine binding site of tubulin. In summary, these results suggest that <b>5b</b> represents a promising tubulin polymerisation inhibitor worthy of further investigation as potential anticancer agents."]}, "AuthorList": [{"Identifier": ["0000-0001-9104-337X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Wenjing", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Fan", "ForeName": "Meiyan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "He", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Food Science and Technology, Shanghai Ocean University, Shanghai, China."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "2166IN72UN", "NameOfSubstance": "naphthalene"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Naphthalenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Polymerization"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Thiazoles"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Tubulin Modulators"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jordan MA, Wilson L.. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253\u201365.", "ArticleIdList": ["15057285"]}, {"Citation": "Sorger PK, Dobles M, Tournebize R, et al. . Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol 1997;9:807\u201314.", "ArticleIdList": ["9425345"]}, {"Citation": "Downing KH, Nogales E.. Tubulin structure: insights into microtubule properties and functions. Curr Opin Struct Biol 1998;8:785\u201391.", "ArticleIdList": ["9914260"]}, {"Citation": "Schwartz EL. Antivascular actions of microtubule-binding drugs. Clin Cancer Res 2009;15:2594\u2013601.", "ArticleIdList": ["PMC2745203", "19351751"]}, {"Citation": "Amos LA. Microtubule structure and its stabilisation. Org Biomol Chem 2004;2:2153\u201360.", "ArticleIdList": ["15280946"]}, {"Citation": "Pasquier E, Andr\u00e9 N, Braguer D.. Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: Implications for cancer treatment. Curr Cancer Drug Targets 2007;7:566\u201381.", "ArticleIdList": ["17896922"]}, {"Citation": "Shao Y-Y, Yin Y, Lian B-P, et al. . Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Eur J Med Chem 2020;190:112105.", "ArticleIdList": ["32035399"]}, {"Citation": "Sigalapalli DK, Pooladanda V, Singh P, et al. . Discovery of certain benzyl/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study. Bioorg Chem 2019;92:103188.", "ArticleIdList": ["31450167"]}, {"Citation": "Stanton RA, Gernert KM, Nettles JH, et al. . Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 2011;31:443\u201381.", "ArticleIdList": ["PMC3155728", "21381049"]}, {"Citation": "Dumontet C, Jordan MA.. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010;9:790\u2013803.", "ArticleIdList": ["PMC3194401", "20885410"]}, {"Citation": "Kaur R, Kaur G, Gill RK, et al. . Recent developments in tubulin polymerization inhibitors: an overview. Eur J Med Chem 2014;87:89\u2013124.", "ArticleIdList": ["25240869"]}, {"Citation": "G\u00fcm\u00fc\u015f M, Yakan M, Koca \u0130.. Recent advances of thiazole hybrids in biological applications. Future Med Chem 2019;11:1979\u201398.", "ArticleIdList": ["31517529"]}, {"Citation": "Mishra R, Sharma PK, Verma PK, et al. . Biological potential of thiazole derivatives of synthetic origin. J Heterocycl Chem 2017;54:2103\u201316."}, {"Citation": "Chhabria MT, Patel S, Modi P, et al. . Thiazole: a review on chemistry, synthesis and therapeutic importance of its derivatives. Curr Top Med Chem 2016;16:2841\u201362.", "ArticleIdList": ["27150376"]}, {"Citation": "Sharma PC, Bansal KK, Sharma A, et al. . Thiazole-containing compounds as therapeutic targets for cancer therapy. Eur J Med Chem 2020;188:112016.", "ArticleIdList": ["31926469"]}, {"Citation": "Ayati A, Emami S, Moghimi S, et al. . Thiazole in the targeted anticancer drug discovery. Future Med Chem 2019;11:1929\u201352.", "ArticleIdList": ["31313595"]}, {"Citation": "Jain S, Pattnaik S, Pathak K, et al. . Anticancer potential of thiazole derivatives: a retrospective review. Mini Rev Med Chem 2018;18:640\u201355.", "ArticleIdList": ["29173166"]}, {"Citation": "Ohsumi K, Hatanaka T, Fujita K, et al. . Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues. Bioorg Med Chem Lett 1998;8:3153\u20138.", "ArticleIdList": ["9873694"]}, {"Citation": "Sun ML, Xu QL, Xu JW, et al. . Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity. PLoS One 2017;12:e0174006.", "ArticleIdList": ["PMC5363846", "28333984"]}, {"Citation": "Shaik TB, Hussaini SMA, Nayak VL, et al. . Rational design and synthesis of 2-anilinopyridinyl-benzothiazole schiff bases as antimitotic agents. Bioorg Med Chem Lett 2017;27:2549\u201358.", "ArticleIdList": ["28400235"]}, {"Citation": "Salehi M, Amini M, Ostad SN, et al. . Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors. Bioorg Med Chem 2013;21:7648\u201354.", "ArticleIdList": ["24238904"]}, {"Citation": "Wang G, Peng Z, Zhang J, et al. . Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site. Bioorg Chem 2018;78:332\u201340.", "ArticleIdList": ["29627654"]}, {"Citation": "Wang G, Liu W, Gong Z, et al. . Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site. J Enzyme Inhib Med Chem 2020;35:139\u201344.", "ArticleIdList": ["PMC6882462", "31724435"]}, {"Citation": "Wang G, Liu W, Tang J, et al. . Design, synthesis, and anticancer evaluation of benzophenone derivatives bearing naphthalene moiety as novel tubulin polymerization inhibitors. Bioorg Chem 2020;104:104265.", "ArticleIdList": ["32919128"]}, {"Citation": "Maya ABS, Perez-Melero C, Mateo C, et al. . Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. J Med Chem 2005;48:556\u201368.", "ArticleIdList": ["15658869"]}, {"Citation": "Wang G, Qiu J, Xiao X, et al. . Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents. Bioorg Chem 2018;76:249\u201357.", "ArticleIdList": ["29197743"]}, {"Citation": "Viegas-Junior C, Danuello A, VdS B, et al. . Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 2007;14:1829\u201352.", "ArticleIdList": ["17627520"]}, {"Citation": "Ivasiv V, Albertini C, Goncalves AE, et al. . Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr Top Med Chem 2019;19:1694\u2013711.", "ArticleIdList": ["31237210"]}, {"Citation": "Wang XD, Wei W, Wang PF, et al. . Novel 3-arylfuran-2(5h)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. Bioorg Med Chem 2014;22:3620\u20138.", "ArticleIdList": ["24882676"]}, {"Citation": "Xiao ZP, Wang XD, Wang PF, et al. . Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. Eur J Med Chem 2014;80:92\u2013100.", "ArticleIdList": ["24769347"]}, {"Citation": "Hao S-Y, Qi Z-Y, Wang S, et al. . Synthesis and bioevaluation of n-(3,4,5-trimethoxyphenyl)-1h-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects. Bioorg Med Chem 2021;31:115985.", "ArticleIdList": ["33421913"]}, {"Citation": "Mustafa M, Anwar S, Elgamal F, et al. . Potent combretastatin a-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study. Eur J Med Chem 2019;183:111697.", "ArticleIdList": ["31536891"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "26", "Hour": "12", "Minute": "19"}, {"Year": "2021", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34309466", "PMC8317958", "10.1080/14756366.2021.1958213"]}}], "PubmedBookArticle": []}